The Effect of Early Time-Restricted Eating vs Later Time-Restricted Eating on Weight Loss and Metabolic Health

超重 医学 胰岛素抵抗 血糖性 减肥 随机对照试验 科克伦图书馆 背景(考古学) 内科学 内分泌学 胰岛素 肥胖 血压 进食行为 葡萄糖稳态 生物 古生物学
作者
Juanhong Liu,Yi Pan,Feng Liu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
卷期号:108 (7): 1824-1834 被引量:30
标识
DOI:10.1210/clinem/dgad036
摘要

Abstract Context It remains controversial whether the choice of the daily eating window early or later in time-restricted eating (TRE) intervention (early or later TRE) has different effects on weight loss and metabolic health. Objective A network meta-analysis was performed to evaluate the efficacy between early and later TRE in adults with obesity or overweight. Methods We searched PubMed, Embase, Web of Science, and Cochrane Library for randomized controlled trials (RCTs) published until October 16, 2022. We conducted a network meta-analysis to evaluate the efficacy of early and later TRE on body weight and metabolic parameters, including glycemic metabolism, blood pressure, and lipid profiles. Results Twelve RCTs with 730 obese or overweight adults were included in this meta-analysis. Early TRE and later TRE both elicited moderate reductions in body weight and insulin resistance (IR) (homeostasis model assessment of IR) when compared to non-TRE. Interestingly, early TRE showed more effectiveness than later TRE in improving IR (early vs later TRE: −0.44; 95% CI, −0.86 to −0.02; P < .05), whereas no statistically significant difference was detected in weight loss (early vs later TRE: −0.31 kg; 95% CI, −1.15 to 0.53 kg; P >.05). In addition, early TRE rather than later TRE showed significant benefits in glycemic metabolism and blood pressure when compared to non-TRE. No significant differences between early and later TRE were observed for fasting blood glucose, blood pressure, and lipid profiles. Conclusion This meta-analysis suggests that people may choose early TRE for more effective weight management and metabolic benefits. Nevertheless, further large-scale RCTs are warranted to verify our findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wwb完成签到,获得积分10
刚刚
张自信完成签到,获得积分10
1秒前
华仔应助VDC采纳,获得10
1秒前
嘟嘟完成签到,获得积分10
2秒前
卡卡完成签到,获得积分10
2秒前
2秒前
十三发布了新的文献求助10
2秒前
2秒前
3秒前
3秒前
甩看文献发布了新的文献求助10
3秒前
wang完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
4秒前
LONG完成签到,获得积分10
5秒前
5秒前
甜蜜秋蝶完成签到,获得积分10
5秒前
6秒前
TT发布了新的文献求助10
7秒前
啊实打实发布了新的文献求助10
7秒前
yam001发布了新的文献求助30
8秒前
Stanley完成签到,获得积分10
8秒前
LONG发布了新的文献求助10
8秒前
亮亮发布了新的文献求助50
8秒前
LZQ应助细心的小蜜蜂采纳,获得30
9秒前
艺玲发布了新的文献求助10
9秒前
小二郎应助Seven采纳,获得10
9秒前
设计狂魔完成签到,获得积分10
9秒前
9秒前
10秒前
韭黄发布了新的文献求助10
10秒前
科研小白完成签到,获得积分10
10秒前
11秒前
9℃发布了新的文献求助10
11秒前
甩看文献完成签到,获得积分10
11秒前
11秒前
欣喜书桃关注了科研通微信公众号
12秒前
12秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527723
求助须知:如何正确求助?哪些是违规求助? 3107826
关于积分的说明 9286663
捐赠科研通 2805577
什么是DOI,文献DOI怎么找? 1539998
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709762